NUCB1 and hepatocellular carcinoma: NUC has been shown to decrease the risk of developing HCC [15, 16]; however, patients with chronic HBV are still at the risk for developing HCC [17, 18], even when they have maintained virologic remission under long-term therapy with NA(s), particularly in patients with cirrhosis [19, 20].